Sanofi-Aventis Circles Genzyme for Potential Deal – Wall Street Journal
By Dr. Matthew Watson
 Reuters India | Sanofi-Aventis Circles Genzyme for Potential Deal Wall Street Journal France's Sanofi-Aventis SA has made an informal acquisition approach to biotechnology drug maker Genzyme ... Sanofi Said to Have Offered to Make a Bid for GenzymeNew York Times Genzyme stock soars on reports it could be soldBoston Globe Report: Sanofi-Aventis, Genzyme talk acquisitionThe Associated Press French Tribune -TradersHuddle.com -MarketWatch all 236 news articles » |
Uncategorized
Comments Off on Sanofi-Aventis Circles Genzyme for Potential Deal – Wall Street Journal |
July 26th, 2010
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research